PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.09M | -18.04M | -18.04M | -21.06M | -21.21M |
| Total Depreciation and Amortization | 24.00K | 34.00K | 33.00K | 31.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | 982.00K | 802.00K | 686.00K | 962.00K |
| Change in Net Operating Assets | 2.30M | -2.66M | 13.00K | 522.00K | 1.91M |
| Cash from Operations | -14.58M | -19.68M | -17.19M | -19.82M | -18.30M |
| Capital Expenditure | -- | -- | -15.00K | 1.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 1.00K | 30.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.23M | 20.82M | 18.46M | 12.03M | 10.97M |
| Cash from Investing | -12.23M | 20.82M | 18.44M | 12.03M | 10.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.00K | -- | 392.00K | 0.00 | 103.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.00K | -- | 392.00K | 0.00 | 103.00K |
| Foreign Exchange rate Adjustments | 0.00 | 2.00K | -1.00K | 2.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.66M | 1.15M | 1.65M | -7.79M | -7.21M |